ID   PC-B-148CA
AC   CVCL_B7I2
DR   cancercelllines; CVCL_B7I2
DR   Wikidata; Q112930253
RX   PubMed=34651665;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 155.7 +- 5.2 hours (PubMed=34651665).
CC   Karyotypic information: 47-58 chromosomes with loss of both copies of chr X (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; 1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=34651665).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34651665
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 11,12
ST   D19S433: 13.2,14.2
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 14,17
ST   FGA: 18
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=34651665; DOI=10.3892/or.2021.8205;
RA   Thongchot S., Jamjuntra P., Prasopsiri J., Thuwajit P., Sawasdee N.,
RA   Poungvarin N., Warnnissorn M., Sa-nguanraksa D., O-Charoenrat P.,
RA   Yenchitsomanus P.-T., Thuwajit C.;
RT   "Establishment and characterization of novel highly aggressive
RT   HER2-positive and triple-negative breast cancer cell lines.";
RL   Oncol. Rep. 46:254.1-254.13(2021).
//